| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 183 | 2018 |
| Breast cancer under age 40: a different approach D Ribnikar, JM Ribeiro, D Pinto, B Sousa, AC Pinto, E Gomes, EC Moser, ... Current treatment options in oncology 16, 1-24, 2015 | 102 | 2015 |
| Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy C Rebelo de Almeida, RV Mendes, A Pezzarossa, J Gago, C Carvalho, ... Communications biology 3 (1), 299, 2020 | 48 | 2020 |
| Review on the clinical use of eribulin mesylate for the treatment of breast cancer O Aseyev, JM Ribeiro, F Cardoso Expert Opinion on Pharmacotherapy 17 (4), 589-600, 2016 | 28 | 2016 |
| Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: a systematic review D Presti, FG Dall’Olio, B Besse, JM Ribeiro, A Di Meglio, D Soldato Critical Reviews in Oncology/Hematology 177, 103773, 2022 | 23 | 2022 |
| Comparison of management and outcomes in ERBB2-low vs ERBB2-zero metastatic breast cancer in France O de Calbiac, A Lusque, A Mailliez, T Bachelot, L Uwer, ... JAMA network open 5 (9), e2231170-e2231170, 2022 | 19 | 2022 |
| Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: a multi-institutional observational study AR Ferreira, A Palha, L Correia, P Filipe, V Rodrigues, A Miranda, ... The Breast 37, 107-113, 2018 | 12 | 2018 |
| Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on … J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, ... The Journal of pathology 260 (5), 498-513, 2023 | 11 | 2023 |
| ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast E Agostinetto, G Nader-Marta, M Paesmans, L Ameye, I Veys, L Buisseret, ... Future Oncology 18 (22), 2383-2392, 2022 | 10 | 2022 |
| Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment J Ribeiro, B Sousa, F Cardoso European Journal of Cancer Supplements 11 (2), 3-22, 2013 | 10 | 2013 |
| Effectiveness of adjuvant ovarian function suppression in premenopausal women with early breast cancer: A multicenter cohort study AR Ferreira, J Ribeiro, A Miranda, A Mayer, JL Passos-Coelho, M Brito, ... Clinical Breast Cancer 19 (5), e654-e667, 2019 | 9 | 2019 |
| A estratigrafia, a evolução tectônica e o diamante do Grupo Bauru da região de Poxoréu, MT, Brasil RK Weska, DB Rosa, JRT Pisani, J ARRAIS, MAC Maciel, JM Ribeiro, ... Simpósio Brasileiro de Geologia do Diamante 1, 208-228, 1993 | 9 | 1993 |
| Targeted axillary dissection after chemotherapy: feasibility study with clip and carbon dye tattoo–Neotarget Trial D Pinto, E Batista, P Gouveia, C Mavioso, J Anacleto, J Ribeiro, B Sousa, ... Breast Care 17 (2), 166-171, 2022 | 8 | 2022 |
| Breast Cancer in young women O Gentilini, AH Partridge, O Pagani Springer, 2020 | 8 | 2020 |
| Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast … DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, ... The Journal of pathology 260 (5), 514-532, 2023 | 7 | 2023 |
| Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort study AR Ferreira, A Palha, L Correia, P Filipe, V Rodrigues, L Costa, A Miranda, ... The Breast 29, 68-73, 2016 | 6 | 2016 |
| Zoledronic Acid: Its Use in the Treatment of Breast Cancer IV Luís, S Casimiro, J Ribeiro, L Costa Clinical Medicine Insights: Therapeutics 2, CMT. S2353, 2010 | 4 | 2010 |
| Implementing a PROACTive care pathway to empower and support survivors of breast cancer MA Franzoi, L Degousée, E Martin, PM Semedo, M Aupomerol, D Soldato, ... JCO Oncology Practice 19 (6), 353-361, 2023 | 3 | 2023 |
| Highlights from the Tenth European Breast Cancer Conference (EBCC10), Amsterdam, 9–11 March 2016 J Ribeiro, MJ Cardoso ecancermedicalscience 10, 2016 | 3 | 2016 |
| Infracentimetric HER-2 positive breast tumours—review of the literature. DF Reis Silva, JM Ribeiro Ecancermedicalscience 9, 2015 | 3 | 2015 |
